information provided by the Illinois Department of Public Health
SPRINGFIELD, Ill. (April 23, 2020) – Two additional Community-Based Testing Sites (CBTS) are opening to the public this week to help test Illinoisans for COVID-19. These new sites will open this week in Aurora (Wednesday) and Rockford (Friday). Illinois Community-Based Testing Sites are open seven days a week to test individuals with COVID-19 symptoms.
“Greater testing capacity is needed so that healthcare workers, first responders and those who continue to be on the job can be tested before they unknowingly spread the virus to others,” said IDPH Director Dr. Ngozi Ezike. “Testing is essential to identify those who is infected. More testing will help us end this pandemic sooner.”
All individuals with COVID-19 symptoms—cough or shortness of breath, and fever—can be tested.
Testing sites are available in Harwood Heights, Bloomington, Markham, Aurora, and Rockford (opens 4/24).
Anyone who will be tested must be seated at a functioning vehicle window. Once you get in line at the CBTS, you will not be permitted to exit your car. For the safety of the testing personnel, the drive-thru sites will not be able to accommodate walk-up individuals. Individuals must arrive in a vehicle.
While this is a free service, you will be asked to show photo identification and healthcare employee or first responder ID/badge, if applicable.
Due to the demand for this service, we anticipate there could be significant wait times associated with these drive-thru community-based testing sites. Please be patient. If you are experiencing a medical emergency, you are urged to call your doctor or emergency department to seek immediate care and instructions.
Dozens of additional commercial testing sites are also available throughout the state, further adding to the state’s testing capacity. For the most up-to-date list of these sites, visit https://coronavirus.illinois.gov/s/testing-sites. There residents can also find information on eligibility for testing and contact information for each testing site.